The NHS Confederation has published a report exploring health economics in the NHS, with contributions from a range of leaders and innovators, including our own Prof Phil Richardson.
Read More
The proposed new NHS England (NHSE) systems for specialised commissioning are arguably the highest risk of all current dynamics, both for the NHS and for suppliers. Key aspects of policy...
Read More
With so many patients left waiting for NHS care, what will the long-term impact be? How can Pharma and Medtech support the NHS with systematic challenges, like waiting? Where can...
Read More
How is the NHS balancing competing challenges as we head through integration and towards winter? How are priorities set and what does system planning look like in primary care? On...
Read More
On 1st July we saw the introduction of legislation for Integrated Care Systems (ICSs) in the NHS. In the weeks since, what has changed for healthcare leaders, practitioners and patients?...
Read More
What roles and responsibilities do Clinical Pharmacists have in the NHS? How can Pharma and Medtech engage Clinical Pharmacists, and how can industry best support these new decision-makers? In this...
Read More
As the NHS takes steps towards a more integrated future, how are systems and care pathways transforming? How is change being implemented, and what does this look like in reality...
Read More
Our experts in health economics, value communication, design and digital discussed how to craft digital payer value communication tools to meet the needs of internal stakeholders, including market access teams...
Read More
What does population health management mean for the NHS, for patients, and for industry? How will the NHS translate population health management into impactful service change and what will this...
Read More
Planning in a volatile environment: how will the NHS reconcile its competing priorities and operational planning to meet its challenges? What does the ‘2022/23 priorities and operational planning guidance’ document...
Read More
